Keyphrases
Triple-negative Breast Cancer
100%
Immunotherapy Targets
100%
CRISPR Interference (CRISPRi)
100%
Immune Evasion
66%
Knock
33%
Tumor
33%
Inhibit Tumor
33%
Tumor Growth
33%
Breast Cancer Patients
33%
Tumor Progression
33%
Therapeutic Target
33%
Cancer Types
33%
Therapeutic Strategies
33%
Tumor-immune System
33%
Transcriptomics
33%
Tumor Immunity
33%
Favorable Prognosis
33%
Tumor Initiation
33%
Tumor Microenvironment
33%
Immunomodulator
33%
Tumor Immune Escape
33%
Immune Signaling
33%
Immune Escape
33%
Anticancer Therapeutics
33%
Syngeneic Mouse Model
33%
Interferon Signaling
33%
Immune Landscape
33%
Single-cell RNA Sequencing Analysis
33%
Immunology and Microbiology
Immunotherapy
100%
Immune Evasion
100%
Clustered Regularly Interspaced Short Palindromic Repeat
100%
Interferon
50%
Immunity
50%
RNA Sequence
50%
Syngenic
50%
Immunomodulating Drug
50%
Immune Escape
50%
Transcriptomics
50%
Immune Landscape
50%
Biochemistry, Genetics and Molecular Biology
Immunity
100%
CRISPR
100%
Tumor Progression
66%
Immune Evasion
66%
Interferon
33%
Syngenic
33%
Transcriptomics
33%
RNA Sequence
33%
Tumor Initiation
33%
Anticancer
33%
Medicine and Dentistry
Melengestrol Acetate
100%